Michael Joseph Rybak (Michael J Rybak)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 71

Top Topics

Pseudomonas Aeruginosa

Biofilm Formation

Top Venues

Microbiology spectrum

Antimicrobial agents and chemotherapy

Pharmacotherapy

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Ashlan J Kunz Coyne, Callan Bleick, Kyle Stamper, Razieh Kebriaei, Arnold S Bayer, Susan M Lehman, Michael Joseph Rybak
Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model. Antimicrobial agents and chemotherapy 68 (4) (2024)
Jacinda C Abdul-Mutakabbir, Nana Sakyi Opoku, Karen K Tan, Peter A Jorth, Victor Nizet, Hansel M Fletcher, Keith S Kaye, Michael Joseph Rybak
Determining Susceptibility and Potential Mediators of Resistance for the Novel Polymyxin Derivative, SPR206, in Acinetobacter baumannii . Antibiotics (Basel, Switzerland) 13 (1) (2024)
Ashlan J Kunz Coyne, Callan Bleick, Kyle Stamper, Razieh Kebriaei, Arnold S Bayer, Susan M Lehman, Michael Joseph Rybak
Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model. Antimicrobial agents and chemotherapy 68 (4) (2024)
Ashlan J Kunz Coyne, Kyle Stamper, Callan Bleick, Razieh Kebriaei, Susan M Lehman, Michael Joseph Rybak
Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms. Microbiology spectrum 12 (4) (2024)
Ashlan J Kunz Coyne, Callan Bleick, Kyle Stamper, Razieh Kebriaei, Arnold S Bayer, Susan M Lehman, Michael Joseph Rybak
Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model. Antimicrobial agents and chemotherapy 68 (4) (2024)
Amer El Ghali, Ashlan J Kunz Coyne, Kristen Lucas, Molly Tieman, Xhilda Xhemali, Suet-Ping Lau, Gabriela Iturralde, Andrew Purdy, Dana J Holger, Esther Garcia, Michael P Veve, Michael Joseph Rybak
Cefiderocol: early clinical experience for multi-drug resistant gram-negative infections. Microbiology spectrum 12 (2) (2024)
Ashlan J Kunz Coyne, Kyle Stamper, Callan Bleick, Razieh Kebriaei, Susan M Lehman, Michael Joseph Rybak
Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms. Microbiology spectrum 12 (4) (2024)
Ashlan J Kunz Coyne, Mirna Eshaya, Callan Bleick, Samantha Vader, Biswajit Biswas, Melanie Wilson, Michael V Deschenes, Jose Alexander, Susan M Lehman, Michael Joseph Rybak
Exploring synergistic and antagonistic interactions in phage-antibiotic combinations against ESKAPE pathogens. Microbiology spectrum (2024)
Amer El Ghali, Ashlan J Kunz Coyne, Kristen Lucas, Molly Tieman, Xhilda Xhemali, Suet-Ping Lau, Gabriela Iturralde, Andrew Purdy, Dana J Holger, Esther Garcia, Michael P Veve, Michael Joseph Rybak
Cefiderocol: early clinical experience for multi-drug resistant gram-negative infections. Microbiology spectrum 12 (2) (2024)
Amer El Ghali, Ashlan J Kunz Coyne, Kristen Lucas, Molly Tieman, Xhilda Xhemali, Suet-Ping Lau, Gabriela Iturralde, Andrew Purdy, Dana J Holger, Esther Garcia, Michael P Veve, Michael Joseph Rybak
Cefiderocol: early clinical experience for multi-drug resistant gram-negative infections. Microbiology spectrum (2024)
Ashlan J Kunz Coyne, Callan Bleick, Kyle Stamper, Razieh Kebriaei, Arnold S Bayer, Susan M Lehman, Michael Joseph Rybak
Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model. Antimicrobial agents and chemotherapy (2024)
Ashlan J Kunz Coyne, Callan Bleick, Kyle Stamper, Razieh Kebriaei, Arnold S Bayer, Susan M Lehman, Michael Joseph Rybak
Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model. Antimicrobial agents and chemotherapy 68 (4) (2024)
Jacinda C Abdul-Mutakabbir, Nana Sakyi Opoku, Karen K Tan, Peter A Jorth, Victor Nizet, Hansel M Fletcher, Keith S Kaye, Michael Joseph Rybak
Determining Susceptibility and Potential Mediators of Resistance for the Novel Polymyxin Derivative, SPR206, in Acinetobacter baumannii . Antibiotics (Basel, Switzerland) 13 (1) (2024)
Ashlan J Kunz Coyne, Kyle Stamper, Callan Bleick, Razieh Kebriaei, Susan M Lehman, Michael Joseph Rybak
Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms. Microbiology spectrum 12 (4) (2024)
Ashlan J Kunz Coyne, Kyle Stamper, Callan Bleick, Razieh Kebriaei, Susan M Lehman, Michael Joseph Rybak
Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms. Microbiology spectrum (2024)
Amer El Ghali, Ashlan J Kunz Coyne, Kristen Lucas, Molly Tieman, Xhilda Xhemali, Suet-Ping Lau, Gabriela Iturralde, Andrew Purdy, Dana J Holger, Esther Garcia, Michael P Veve, Michael Joseph Rybak
Cefiderocol: early clinical experience for multi-drug resistant gram-negative infections. Microbiology spectrum 12 (2) (2024)
Ashlan J Kunz Coyne, Kyle Stamper, Callan Bleick, Razieh Kebriaei, Susan M Lehman, Michael Joseph Rybak
Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms. Microbiology spectrum 12 (4) (2024)
Jacinda C Abdul-Mutakabbir, Nana Sakyi Opoku, Karen K Tan, Peter A Jorth, Victor Nizet, Hansel M Fletcher, Keith S Kaye, Michael Joseph Rybak
Determining Susceptibility and Potential Mediators of Resistance for the Novel Polymyxin Derivative, SPR206, in Acinetobacter baumannii . Antibiotics (Basel, Switzerland) 13 (1) (2024)
Ashlan J Kunz Coyne, Callan Bleick, Kyle Stamper, Razieh Kebriaei, Arnold S Bayer, Susan M Lehman, Michael Joseph Rybak
Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model. Antimicrobial agents and chemotherapy 68 (4) (2024)
Ashlan J Kunz Coyne, Callan Bleick, Kyle Stamper, Razieh Kebriaei, Arnold S Bayer, Susan M Lehman, Michael Joseph Rybak
Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model. Antimicrobial agents and chemotherapy 68 (4) (2024)
Jacinda C Abdul-Mutakabbir, Nana Sakyi Opoku, Karen K Tan, Peter A Jorth, Victor Nizet, Hansel M Fletcher, Keith S Kaye, Michael Joseph Rybak
Determining Susceptibility and Potential Mediators of Resistance for the Novel Polymyxin Derivative, SPR206, in Acinetobacter baumannii . Antibiotics (Basel, Switzerland) 13 (1) (2024)
Amer El Ghali, Ashlan J Kunz Coyne, Kaylee E Caniff, Callan Bleick, Michael Joseph Rybak
Sulbactam-durlobactam: A Novel β-lactam-β-lactamase Inhibitor Combination Targeting Carbapenem-Resistant Acinetobacter baumannii Infections. Pharmacotherapy (2023)
Ashlan J Kunz Coyne, Amer El Ghali, Kristen Lucas, Paige Witucki, Nicholas Rebold, Dana J Holger, Michael P Veve, Michael Joseph Rybak
High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production. Open forum infectious diseases 10 (3) (2023)
Nicholas Rebold, Abdalhamid M Lagnf, Sara Alosaimy, Dana J Holger, Paige Witucki, Andrew Mannino, Michelle Dierker, Kristen Lucas, Ashlan J Kunz Coyne, Amer El Ghali, Kaylee E Caniff, Michael P Veve, Michael Joseph Rybak
Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure. Microbiology spectrum 11 (1) (2023)
Kaylee E Caniff, Nicholas Rebold, Michael Joseph Rybak
Oral stepdown in Gram-positive bloodstream infections: A step in the right direction. Pharmacotherapy (2023)
Nicholas Rebold, Abdalhamid M Lagnf, Sara Alosaimy, Dana J Holger, Paige Witucki, Andrew Mannino, Michelle Dierker, Kristen Lucas, Ashlan J Kunz Coyne, Amer El Ghali, Kaylee E Caniff, Michael P Veve, Michael Joseph Rybak
Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure. Microbiology spectrum 11 (1) (2023)
Ashlan J Kunz Coyne, Shelbye Herbin, Kaylee E Caniff, Michael Joseph Rybak
Steno-sphere: Navigating the Enigmatic World of Emerging Multidrug-Resistant Stenotrophomonas maltophilia. Pharmacotherapy (2023)
Michael J Rybak, Kyle C Stamper, Katherine L Lev, Razieh Kebriaei, Dana J Holger, Jacinda C Abdul-Mutakabbir, Ashlan J Kunz Coyne, Michael Joseph Rybak
Evaluation of Omadacycline Alone and in Combination with Rifampin against Staphylococcus aureus and Staphylococcus epidermidis in an In Vitro Pharmacokinetic/Pharmacodynamic Biofilm Model. Antimicrobial agents and chemotherapy (2023)
Ashlan J Kunz Coyne, Sara Alosaimy, Kristen Lucas, Abdalhamid M Lagnf, Taylor Morrisette, Kyle C Molina, Alaina DeKerlegand, Melanie Rae Schrack, S Lena Kang-Birken, Athena L V Hobbs, Jazmin Agee, Nicholson B Perkins, Mark Biagi, Michael Pierce, James Truong, Justin Andrade, Jeannette Bouchard, Tristan Gore, Madeline A King, Benjamin M Pullinger, Kimberly C Claeys, Shelbye Herbin, Reese Cosimi, Serina Tart, Michael P Veve, Bruce M Jones, Leonor M Rojas, Amy K Feehan, Marco R Scipione, Jing J Zhao, Paige Witucki, Michael Joseph Rybak
Eravacycline, the first four years: health outcomes and tolerability data for 19 hospitals in 5 U.S. regions from 2018 to 2022. Microbiology spectrum (2023)
Dana J Holger, Amer El Ghali, Natasha Bhutani, Katherine L Lev, Kyle Stamper, Razieh Kebriaei, Ashlan J Kunz Coyne, Taylor Morrisette, Rahi Shah, Jose Alexander, Susan M Lehman, Laura J Rojas, Steven H Marshall, Robert A Bonomo, Michael Joseph Rybak
Phage-antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa in in vitro static and dynamic biofilm models. Antimicrobial agents and chemotherapy (2023)
Kaylee E Caniff, Nicholas Rebold, Michael Joseph Rybak
Oral stepdown in Gram-positive bloodstream infections: A step in the right direction. Pharmacotherapy (2023)
Ashlan J Kunz Coyne, Carolina Orzol, Michael P Veve, Michael Joseph Rybak
Weighing the Odds: Novel β-Lactam/β-Lactamase Inhibitor Use in Hospital-Acquired and Ventilator-Associated Pseudomonas aeruginosa Pneumonia for Patients Who Are Morbidly Obese. Open forum infectious diseases 10 (9) (2023)
Nagendra N Mishra, Wessam Abdelhady, Ahmed M Elsayed, Christian Lapitan, Richard A Proctor, Michael Joseph Rybak, Jose M Miro, Arnold S Bayer
Combinations of Daptomycin plus Ceftriaxone, but Not Ascending Daptomycin Dose-Regimens, Are Effective in Experimental Endocarditis Caused by Streptococcus mitis -oralis Strains: Target Tissue Clearances and Prevention of Emergence of Daptomycin-Resistance. Antimicrobial agents and chemotherapy (2023)
Ashlan J Kunz Coyne, Amer El Ghali, Kristen Lucas, Paige Witucki, Nicholas Rebold, Dana J Holger, Michael P Veve, Michael Joseph Rybak
High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production. Open forum infectious diseases 10 (3) (2023)
Nicholas Rebold, Abdalhamid M Lagnf, Sara Alosaimy, Dana J Holger, Paige Witucki, Andrew Mannino, Michelle Dierker, Kristen Lucas, Ashlan J Kunz Coyne, Amer El Ghali, Kaylee E Caniff, Michael P Veve, Michael Joseph Rybak
Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure. Microbiology spectrum 11 (1) (2023)
Kaylee E Caniff, Nicholas Rebold, Michael Joseph Rybak
Oral stepdown in Gram-positive bloodstream infections: A step in the right direction. Pharmacotherapy 43 (3) (2023)
Amer El Ghali, Taylor Morrisette, Sara Alosaimy, Kristen Lucas, Maria G Tupayachi-Ortiz, Raaga Vemula, Carly Wadle, Julie V Philley, Carlos Mejia-Chew, Yasir Hamad, Ryan W Stevens, John D Zeuli, Andrew J Webb, Christina T Fiske, Anahit Simonyan, Christo L Cimino, Mehriban Mammadova, Virginia E Umana, Rodrigo Hasbun, Saira Butt, Kyle C Molina, Michael Thomas, Emily A Kaip, Jeannette Bouchard, Tristan W Gore, Catessa Howard, M Gabriela Cabanilla, Dana J Holger, Jeremy J Frens, Melissa Barger, Aaron Ong, Keira A Cohen, Michael Joseph Rybak
Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections: a retrospective, multicenter cohort of real-world health outcomes. Antimicrobial agents and chemotherapy (2023)
Razieh Kebriaei, Susan M Lehman, Rahi M Shah, Kyle C Stamper, Ashlan J Kunz Coyne, Dana Holger, Amer El Ghali, Michael Joseph Rybak
Optimization of Phage-Antibiotic Combinations against Staphylococcus aureus Biofilms. Microbiology spectrum (2023)
Kaylee E Caniff, Nicholas Rebold, Michael Joseph Rybak
Oral stepdown in Gram-positive bloodstream infections: A step in the right direction. Pharmacotherapy 43 (3) (2023)
Amer El Ghali, Kyle Stamper, Ashlan J Kunz Coyne, Dana J Holger, Razieh Kebriaei, Jose Alexander, Susan M Lehman, Michael Joseph Rybak
Ciprofloxacin in combination with bacteriophage cocktails against multi-drug resistant Pseudomonas aeruginosa in ex vivo simulated endocardial vegetation models. Antimicrobial agents and chemotherapy (2023)
Ashlan J Kunz Coyne, Kyle Stamper, Amer El Ghali, Razieh Kebriaei, Biswajit Biswas, Melanie Wilson, Michael V Deschenes, Truc T Tran, César A Arias, Michael Joseph Rybak
Phage-Antibiotic Cocktail Rescues Daptomycin and Phage Susceptibility against Daptomycin-Nonsusceptible Enterococcus faecium in a Simulated Endocardial Vegetation Ex Vivo Model. Microbiology spectrum (2023)
Nicholas Rebold, Abdalhamid M Lagnf, Sara Alosaimy, Dana J Holger, Paige Witucki, Andrew Mannino, Michelle Dierker, Kristen Lucas, Ashlan J Kunz Coyne, Amer El Ghali, Kaylee E Caniff, Michael P Veve, Michael Joseph Rybak
Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure. Microbiology spectrum (2023)
Kaylee E Caniff, Nicholas Rebold, Michael Joseph Rybak
Oral stepdown in Gram-positive bloodstream infections: A step in the right direction. Pharmacotherapy 43 (3) (2023)
Nicholas Rebold, Abdalhamid M Lagnf, Sara Alosaimy, Dana J Holger, Paige Witucki, Andrew Mannino, Michelle Dierker, Kristen Lucas, Ashlan J Kunz Coyne, Amer El Ghali, Kaylee E Caniff, Michael P Veve, Michael Joseph Rybak
Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure. Microbiology spectrum 11 (1) (2023)
Razieh Kebriaei, Katherine L Lev, Rahi M Shah, Kyle C Stamper, Dana J Holger, Michael J Rybak, Ashlan J Kunz Coyne, Susan M Lehman, Michael Joseph Rybak
Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections In Vitro : Bacteriophage-Antibiotic Combination. Microbiology spectrum 10 (2) (2022)
Mark A T Blaskovich, Karl A Hansford, Mark S Butler, Soumya Ramu, Angela M Kavanagh, Angie M Jarrad, Anggia Prasetyoputri, Miranda E Pitt, Johnny X Huang, Fredrik Lindahl, Zyta Maria Ziora, Tanya Bradford, Craig Muldoon, Premraj Rajaratnam, Ruby Pelingon, David J Edwards, Bing Zhang, Maite Amado, Alysha G Elliott, Johannes Zuegg, Lachlan J M Coin, Anne-Kathrin Woischnig, Nina Khanna, Elena Breidenstein, Anna Stincone, Clive S Mason, Nawaz Khan, Hye Kyung Cho, Melissa J Karau, Kerryl E Greenwood-Quaintance, Robin Patel, Mandy Wootton, Meagan L James, Melanie L Hutton, Dena Lyras, Abiodun David Ogunniyi, Layla K Mahdi, Darren J Trott, Xiaoqian Wu, Samantha Niles, Kim Lewis, Jordan R Smith, Katie E Barber, Juwon Yim, Seth Alan Rice, Michael Joseph Rybak, Chad R Ishmael, Kellyn R Hori, Nicholas M Bernthal, Kevin P Francis, Jason A Roberts, David L Paterson, Matthew A Cooper
A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections. Science translational medicine 14 (662) (2022)
Dana J Holger, Katherine L Lev, Razieh Kebriaei, Taylor Morrisette, Rahi Shah, Jose Alexander, Susan M Lehman, Michael Joseph Rybak
Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: In vitro synergy testing. Journal of applied microbiology 133 (3) (2022)
Dana J Holger, Ashlan J Kunz Coyne, Jing J Zhao, Avnish Sandhu, Hossein Salimnia, Michael Joseph Rybak
Novel Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Necrotizing Pneumonia Complicated by Empyema: A Case Report. Open forum infectious diseases 9 (4) (2022)
Gina A Suh, Thomas P Lodise, Pranita D Tamma, Jane M Knisely, Jose Alexander, Saima Aslam, Karen D Barton, Erica Bizzell, Katherine M C Totten, Joseph L Campbell, Benjamin K Chan, Scott A Cunningham, Katherine E Goodman, Kerryl E Greenwood-Quaintance, Anthony D Harris, Shayla E Hesse, Anthony Maresso, Veronique Nussenblatt, David T Pride, Michael Joseph Rybak, Zoe Sund, David Van Duin, Daria Van Tyne, Robin Patel, null null
Considerations for the Use of Phage Therapy in Clinical Practice. Antimicrobial agents and chemotherapy 66 (3) (2022)
Nicholas Rebold, Thomas P Lodise, Michael Joseph Rybak
Panacea or oversimplification: Relating AUC and troughs. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 79 (12) (2022)
Katherine Lev, Ashlan J Kunz Coyne, Razieh Kebriaei, Michael J Rybak, Kyle Stamper, Dana J Holger, Gregory S Canfield, Breck A Duerkop, Cesar A Arias, Michael Joseph Rybak
Evaluation of Bacteriophage-Antibiotic Combination Therapy for Biofilm-Embedded MDR Enterococcus faecium . Antibiotics (Basel, Switzerland) 11 (3) (2022)
Ashlan J Kunz Coyne, Kyle Stamper, Razieh Kebriaei, Dana J Holger, Amer El Ghali, Taylor Morrisette, Biswajit Biswas, Melanie Wilson, Michael V Deschenes, Gregory S Canfield, Breck A Duerkop, Cesar A Arias, Michael Joseph Rybak
Phage Cocktails with Daptomycin and Ampicillin Eradicates Biofilm-Embedded Multidrug-Resistant Enterococcus faecium with Preserved Phage Susceptibility. Antibiotics (Basel, Switzerland) 11 (9) (2022)
Sara Alosaimy, Taylor Morrisette, Abdalhamid M Lagnf, Leonor M Rojas, Madeline A King, Benjamin M Pullinger, Athena L V Hobbs, Nicholson B Perkins, Michael P Veve, Jeannette Bouchard, Tristan Gore, Bruce M Jones, James Truong, Justin Andrade, Glen Huang, Reese Cosimi, S Lena Kang-Birken, Kyle C Molina, Mark Biagi, Michael Pierce, Marco R Scipione, Jing J Zhao, Susan L Davis, Michael Joseph Rybak
Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumannii. Microbiology spectrum 10 (5) (2022)
Razieh Kebriaei, Arnold S Bayer, Christian K Lapitan, Michael Joseph Rybak, Greg A Somerville, Nagendra N Mishra
Activity of the Lactate Dehydrogenase Inhibitor Oxamic Acid against the Fermentative Bacterium Streptococcus mitis/oralis : Bactericidal Effects and Prevention of Daptomycin Resistance In Vitro and in an Ex Vivo Model. Antibiotics (Basel, Switzerland) 11 (10) (2022)
Razieh Kebriaei, Kyle C Stamper, Katherine L Lev, Taylor Morrisette, Jacinda C Abdul-Mutakabbir, Raymond Schuch, Dario Lehoux, Michael Joseph Rybak
Exebacase in Addition to Daptomycin against MRSA. Antimicrobial agents and chemotherapy 65 (11) (2021)
Michael Joseph Rybak, Jennifer Le, Thomas P Lodise, Donald P Levine, John S Bradley, Catherine Liu, Bruce A Mueller, Manjunath P Pai, Annie-Wong Beringer, Keith A Rodvold, Holly D Maples
Validity of 2020 vancomycin consensus recommendations and further guidance for practical application. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 78 (15) (2021)
Sara Alosaimy, Abdalhamid M Lagnf, Taylor Morrisette, Marco R Scipione, Jing J Zhao, Sarah C J Jorgensen, Ryan Mynatt, Travis J Carlson, Jinhee Jo, Kevin W Garey, David Allen, Kailynn DeRonde, Ana D Vega, Lilian M Abbo, Veena Venugopalan, Vasilios Athans, Stephen Saw, Kimberly C Claeys, Mathew Miller, Kyle C Molina, Michael Veve, Wesley D Kufel, Lee Amaya, Christine Yost, Jessica Ortwine, Susan L Davis, Michael Joseph Rybak
Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa. Open forum infectious diseases 8 (8) (2021)
Nicholas Rebold, Michael J Rybak, Abdalhamid M Lagnf, Sara Alosaimy, Dana Holger, Katie E Barber, Julie Ann Justo, Kayla Antosz, Travis J Carlson, Jeremy J Frens, Mark J Biagi, Wesley D Kufel, William J Moore, Nicholas J Mercuro, Brian R Raux, Michael Joseph Rybak
Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections. Open forum infectious diseases 8 (12) (2021)
Taylor Morrisette, Katherine L Lev, Gregory S Canfield, Breck A Duerkop, Razieh Kebriaei, Kyle C Stamper, Dana Holger, Susan M Lehman, Smaranda Willcox, Cesar A Arias, Michael Joseph Rybak
Evaluation of Bacteriophage Cocktails Alone and in Combination with Daptomycin Against Daptomycin-Nonsusceptible Enterococcus faecium. Antimicrobial agents and chemotherapy (2021)
Sara Alosaimy, Jacinda C Abdul-Mutakabbir, Razie Kebriaei, Sarah C J Jorgensen, Michael Joseph Rybak
Evaluation of Eravacycline: A Novel Fluorocycline. Pharmacotherapy 40 (3) (2020)
Michael J Rybak, Razieh Kebriaei, Katherine L Lev, Sandra Morales, Michael Joseph Rybak
Bacteriophage Therapeutics: A Primer for Clinicians on Phage-Antibiotic Combinations. Pharmacotherapy 40 (2) (2020)
Jacinda C Abdul-Mutakabbir, Sara Alosaimy, Taylor Morrisette, Razieh Kebriaei, Michael Joseph Rybak
Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug-Resistant Gram-Negative Pathogens. Pharmacotherapy 40 (12) (2020)
Thomas P Lodise, Michael Joseph Rybak
COVID-19: Important Therapy Considerations and Approaches in this Hour of Need. Pharmacotherapy 40 (5) (2020)
Razieh Kebriaei, Katherine L Lev, Kyle C Stamper, Susan M Lehman, Sandra Morales, Michael Joseph Rybak
Bacteriophage AB-SA01 Cocktail in Combination with Antibiotics against MRSA-VISA Strain in an In Vitro Pharmacokinetic/Pharmacodynamic Model. Antimicrobial agents and chemotherapy 65 (1) (2020)
Michael Joseph Rybak, Jennifer Le, Thomas P Lodise, Donald P Levine, John S Bradley, Catherine Liu, Bruce A Mueller, Manjunath P Pai, Annie Wong-Beringer, John C Rotschafer, Keith A Rodvold, Holly D Maples, Benjamin M Lomaestro
Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy 40 (4) (2020)
Pramodini B Kale-Pradhan, Christopher Alan Giuliano, Annelise Jongekrijg, Michael Joseph Rybak
Combination of Vancomycin or Daptomycin and Beta-lactam Antibiotics: A Meta-analysis. Pharmacotherapy 40 (7) (2020)
Michael J Rybak, Katherine L Lev, Razieh Kebriaei, Jacinda C Abdul-Mutakabbir, Kyle C Stamper, Sandra Morales, Susan M Lehman, Gregory S Canfield, Breck A Duerkop, Cesar A Arias, Michael Joseph Rybak
Bacteriophage-Antibiotic Combinations for Enterococcus faecium with Varying Bacteriophage and Daptomycin Susceptibilities. Antimicrobial agents and chemotherapy 64 (9) (2020)
Sara Alosaimy, Sarah C J Jorgensen, Michael Joseph Rybak
The Optimal Use of the Polymyxins Before Their Time Is Up. Pharmacotherapy 39 (1) (2019)
Trang D Trinh, Jordan R Smith, Michael Joseph Rybak
Parenteral Fosfomycin for the Treatment of Multidrug Resistant Bacterial Infections: The Rise of the Epoxide. Pharmacotherapy 39 (11) (2019)
Sarah Christina Jane Jorgensen, Michael Joseph Rybak
Meropenem and Vaborbactam: Stepping up the Battle against Carbapenem-resistant Enterobacteriaceae. Pharmacotherapy 38 (4) (2018)
Juwon Yim, Jordan R Smith, Katie E Barber, Jessica A Hallesy, Michael Joseph Rybak
Evaluation of Pharmacodynamic Interactions Between Telavancin and Aztreonam or Piperacillin/Tazobactam Against Pseudomonas aeruginosa, Escherichia coli and Methicillin-Resistant Staphylococcus aureus. Infectious diseases and therapy 5 (3) (2016)